MutualFirst Financial, Inc. (MFSF) Analysts See $0.49 EPS; Great Point Partners Raised Ptc Therapeutics (Call) (PTCT) Holding

January 16, 2018 - By Hazel Jackson

Great Point Partners Llc increased Ptc Therapeutics Inc (Call) (PTCT) stake by 76.92% reported in 2017Q3 SEC filing. Great Point Partners Llc acquired 200,000 shares as Ptc Therapeutics Inc (Call) (PTCT)’s stock declined 3.95%. The Great Point Partners Llc holds 460,000 shares with $9.21 million value, up from 260,000 last quarter. Ptc Therapeutics Inc (Call) now has $966.29 million valuation. The stock increased 7.28% or $1.58 during the last trading session, reaching $23.29. About 1.30 million shares traded or 33.60% up from the average. PTC Therapeutics, Inc. (NASDAQ:PTCT) has risen 104.51% since January 16, 2017 and is uptrending. It has outperformed by 87.81% the S&P500.

Analysts expect MutualFirst Financial, Inc. (NASDAQ:MFSF) to report $0.49 EPS on February, 7.They anticipate $0.06 EPS change or 13.95% from last quarter’s $0.43 EPS. MFSF’s profit would be $3.62 million giving it 19.59 P/E if the $0.49 EPS is correct. After having $0.50 EPS previously, MutualFirst Financial, Inc.’s analysts see -2.00% EPS growth. It closed at $38.4 lastly. It is down 21.64% since January 16, 2017 and is uptrending. It has outperformed by 4.94% the S&P500.

Among 2 analysts covering Mutualfirst Financial Inc (NASDAQ:MFSF), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Mutualfirst Financial Inc had 6 analyst reports since October 27, 2015 according to SRatingsIntel. On Thursday, June 1 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. The firm earned “Hold” rating on Tuesday, October 3 by Keefe Bruyette & Woods. On Wednesday, July 26 the stock rating was upgraded by DA Davidson to “Neutral”. Keefe Bruyette & Woods maintained MutualFirst Financial, Inc. (NASDAQ:MFSF) on Thursday, December 21 with “Hold” rating. The company was initiated on Thursday, July 21 by DA Davidson.

Investors sentiment increased to 2.07 in Q3 2017. Its up 0.66, from 1.41 in 2017Q2. It is positive, as 5 investors sold MutualFirst Financial, Inc. shares while 10 reduced holdings. 6 funds opened positions while 25 raised stakes. 3.50 million shares or 2.96% more from 3.40 million shares in 2017Q2 were reported. 52,136 are held by Geode Cap Management Ltd Liability Corporation. California State Teachers Retirement System accumulated 9,707 shares. American Intll Inc holds 4,109 shares or 0% of its portfolio. 9,833 were reported by Morgan Stanley. 2,911 are owned by First Quadrant Lp Ca. James Research Inc holds 0.03% or 24,415 shares. Moreover, Deutsche Bank Ag has 0% invested in MutualFirst Financial, Inc. (NASDAQ:MFSF). Federated Pa reported 0% in MutualFirst Financial, Inc. (NASDAQ:MFSF). Royal Bancshares Of Canada reported 35,813 shares. Ameritas Invest has invested 0% in MutualFirst Financial, Inc. (NASDAQ:MFSF). Renaissance Tech Limited Co owns 199,096 shares for 0.01% of their portfolio. Acadian Asset Mgmt Ltd Liability Corp has invested 0% in MutualFirst Financial, Inc. (NASDAQ:MFSF). The Massachusetts-based Rhumbline Advisers has invested 0% in MutualFirst Financial, Inc. (NASDAQ:MFSF). Tower Research Capital Limited Company (Trc) reported 0% of its portfolio in MutualFirst Financial, Inc. (NASDAQ:MFSF). Dimensional Fund Lp stated it has 0.01% of its portfolio in MutualFirst Financial, Inc. (NASDAQ:MFSF).

MutualFirst Financial, Inc. operates as the bank holding firm for the MutualBank that provides various financial services to individuals, and small and mid-sized businesses in the United States. The company has market cap of $283.75 million. It accepts savings deposit, NOW, and demand accounts, as well as certificates of deposit. It has a 20.32 P/E ratio. The firm offers one-to four-family residential property, commercial real estate, construction and development, and commercial business loans; consumer loans, such as auto loans, boat and recreational vehicle loans, loans secured by savings deposits, and credit card and unsecured consumer loans; and adjustable rate loans.

Since July 31, 2017, it had 0 insider purchases, and 6 sales for $951,179 activity. MCVICKER JERRY DEAN sold $63,624 worth of MutualFirst Financial, Inc. (NASDAQ:MFSF) on Monday, December 18. 12,065 shares were sold by HEETER DAVID WAYNE, worth $424,188 on Monday, July 31. The insider VIATER CHARLES J sold 710 shares worth $28,365.

Investors sentiment increased to 1.71 in Q3 2017. Its up 0.79, from 0.92 in 2017Q2. It improved, as 13 investors sold PTCT shares while 28 reduced holdings. 25 funds opened positions while 45 raised stakes. 32.89 million shares or 5.85% more from 31.07 million shares in 2017Q2 were reported. Moore Capital Mngmt Lp reported 50,000 shares. Commercial Bank Of Mellon Corp owns 171,477 shares. Sg Americas Secs Ltd reported 0.01% in PTC Therapeutics, Inc. (NASDAQ:PTCT). Ny State Common Retirement Fund has 0% invested in PTC Therapeutics, Inc. (NASDAQ:PTCT). 318,812 were accumulated by Pinnacle Associate. Parametric Assoc Limited Liability holds 0% or 26,739 shares. Federated Investors Inc Pa reported 2,551 shares. Nationwide Fund owns 21,718 shares or 0% of their US portfolio. Numeric Limited Com stated it has 0.07% of its portfolio in PTC Therapeutics, Inc. (NASDAQ:PTCT). Canada Pension Plan Investment Board, a Ontario – Canada-based fund reported 23,200 shares. Fisher Asset Mgmt Ltd stated it has 173,045 shares or 0% of all its holdings. The New York-based Tower Rech Capital Limited Liability (Trc) has invested 0% in PTC Therapeutics, Inc. (NASDAQ:PTCT). Meeder Asset Management Inc invested in 383 shares. Pennsylvania-based Sei Invs has invested 0% in PTC Therapeutics, Inc. (NASDAQ:PTCT). Royal Fincl Bank Of Canada stated it has 0% of its portfolio in PTC Therapeutics, Inc. (NASDAQ:PTCT).

Among 12 analysts covering PTC Therapeutics (NASDAQ:PTCT), 4 have Buy rating, 1 Sell and 7 Hold. Therefore 33% are positive. PTC Therapeutics had 34 analyst reports since July 31, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, February 24 by Jefferies. RBC Capital Markets maintained the stock with “Hold” rating in Wednesday, July 5 report. The rating was downgraded by Citigroup to “Neutral” on Wednesday, February 24. The rating was maintained by Cowen & Co with “Hold” on Friday, June 30. The company was maintained on Wednesday, August 9 by RBC Capital Markets. Bank of America downgraded it to “Sell” rating and $14.0 target in Thursday, October 26 report. Jefferies initiated the stock with “Hold” rating in Friday, October 23 report. RBC Capital Markets maintained it with “Hold” rating and $15.0 target in Thursday, September 14 report. The firm earned “Sector Perform” rating on Wednesday, February 24 by RBC Capital Markets. The firm has “Outperform” rating given on Friday, October 16 by Oppenheimer.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: